AGFA-GEVAERT Stock Bullish Momentum With A 13.59% Rise Today

(VIANEWS) – The Market ended the session with AGFA-GEVAERT (AGFB.BR) rising 13.59% to €1.22 on Wednesday while BEL 20 dropped 0.57% to €3,728.49. About AGFA-GEVAERT Agfa-Gevaert NV develops, produces, and distributes various analog and digital imaging systems, and IT solutions worldwide. The company's Offset Solutions segment provides commercial, newspaper, and packaging printers; integrated prepress and…

Read More

AFFLUENT MEDICAL Stock Bullish Momentum With A 14.36% Jump On Wednesday

(VIANEWS) – The Market ended the session with AFFLUENT MEDICAL (AFME.PA) rising 14.36% to €2.07 on Wednesday while CAC 40 rose 0.62% to €8,137.58. AFFLUENT MEDICAL’s last close was €1.81, 21.3% below its 52-week high of €2.30. About AFFLUENT MEDICAL Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular…

Read More

ULTIMOVACS Stock Was 15.79% Up Today

(VIANEWS) – The Market ended the session with ULTIMOVACS (ULTI.OL) jumping 15.79% to kr8.80 on Tuesday, after four successive sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.92% to kr1,279.21, following the last session’s downward trend on what was a somewhat up trend exchanging session today. ULTIMOVACS’s last close was kr7.60, 95.74%…

Read More

CASINO GUICHARD Stock Bullish Momentum With A 9.14% Jump On Tuesday

(VIANEWS) – The Market ended the session with CASINO GUICHARD (CO.PA) rising 9.14% to €0.56 on Tuesday while CAC 40 rose 0.84% to €8,087.48. CASINO GUICHARD’s last close was €0.51, 94.16% under its 52-week high of €8.70. About CASINO GUICHARD Casino, Guichard-Perrachon S.A. operates as a food retailer in France, Latin America, and internationally. The…

Read More

VIVORYON Stock Bullish Momentum With A 14.29% Rise Today

(VIANEWS) – The Market ended the session with VIVORYON (VVY.AS) rising 14.29% to €0.58 on Monday while AEX-Index fell 1.12% to €852.32. About VIVORYON Vivoryon Therapeutics N.V., a clinical stage biopharmaceutical company, engages in the research, development, and commercialize small molecule-based medicines. Its pipeline products target toxic pyroglutamate-Abeta (pGlu-Abeta), which inhibits the production of pGlu-Abeta….

Read More